Zenotech Laboratories Limited was initially established as Sunline Technologies Limited in June, 1989 and changed to the present name w.e.f. August 9, 2004. Company is a loan licensing company catering exclusively to Sun Pharmaceutical Industries Limited, Promoter & holding company and they are specialized contract manufacturing services /processing in parenteral depot formulations, ophthalmic, oncology oral & injectables and general injectables. Company's injectables product portfolio primarily serves niche therapy areas like oncology and anesthesiology.
During financial year 2004-05, the Hon'ble High Court of Andhra Pradesh sanctioned the Scheme of Amalgamation with M/s. Zenotech Technologies Limited with effect from November 1st , 2003. The Company had issued 91,82,500 equity shares to erstwhile shareholders of M/s. Zenotech Laboratories Pvt. Ltd.
M/s, Credence Pharmaceuticals Limited and M/s, Hemarus Healthcare Private Limited were merged with the Company, on May 2, 2006 through Scheme of Amalgamation, effective from October 1, 2005. 15 generic chemical oncology products were launched by the Company in India. Besides, the Company launched its anesthesia range of products during 2006.
In 2005-06, M/s, Credence Pharmaceuticals Limited and M/s, Hemarus Healthcare Private Limited got merged with the Company and the Scheme of Amalgamation became effective from October 1, 2005.
Consequent to the consummation of the merger of Ranbaxy Laboratories Limited into SPIL ...on March 24, 2015, SPIL indirectly acquired 46.84 percent of the voting rights held by Ranbaxy in, and control over the Company and became Promoter of the Company along with Daiichi Sankyo Company Limited and resultant, the Open Offer concluded in August 2015.
The Company started production from its newly commissioned Depot Injectable facility in FY 2019-20. It renovated Biotech API manufacturing facility and the same was leased to Sun Pharmaceutical Industries Limited, for their R&D activities effective from July, 2021.
FAQs on Zenotech Laboratories Ltd
1. Can I buy Zenotech Laboratories Ltd from PL Capital? ›
Yes, you can invest in Zenotech Laboratories Ltd shares directly through PL Capital. Our platform provides a seamless and secure way to buy, hold, and track Zenotech Laboratories Ltd stock along with other leading companies listed on the NSE and BSE. Simply open a Demat and trading account with PL Capital, and you’ll be able to trade Zenotech Laboratories Ltd as well as diversify your portfolio across equities, mutual funds, IPOs, and more.
2. Does Zenotech Laboratories Ltd pay dividends? ›
Zenotech Laboratories Ltd does not currently pay dividends. Investors in this case primarily benefit from capital appreciation, where the value of the stock may rise over time depending on business growth and market conditions.
3. What is the current share price of Zenotech Laboratories Ltd ? ›
As of
06-Aug-2026 , 16:01:31 the share price for Zenotech Laboratories Ltd. is ₹ 44.2 on the NSE (Note: Prices are dynamic and update frequently during market hours).
4. What is the 52-week high and low of Zenotech Laboratories Ltd ? ›
The 52-week high and low of Zenotech Laboratories Ltd share price is ₹ 33.55 - ₹ 60 as of
06-Aug-2026 , 16:01:31 .
Open Your Demat Account with PL Capital now
10 Lakh+ Active users
Award Winning research insights
No hidden charges
Start Stock SIP
Start SIP in Zenotech Laboratories Ltd
Invest systematically in stocks with the PL Capital app
